CDPATH

Takeda Pharmaceuticals U.S.A., Inc.

Application Filed: 2020-07-01
Trademark Application Details
Trademark Logo CDPATH

Mark For: CDPATH® trademark registration is intended to cover the category of downloadable predictive analytic software tools for use in patient healthcare. [all]

Status

2021-09-04 UTC
LIVE APPLICATION Published for Opposition
A pending trademark application has been examined by the Office and has been published in a way that provides an opportunity for the public to oppose its registration.


Research OneLook Acronym Finder
Serial Number90030931
Registration Number6732492
Mark Literal ElementsCDPATH
Mark Drawing Type4 - STANDARD CHARACTER MARK
Mark TypeTRADEMARK. SERVICE MARK
RegisterPRINCIPAL
Current LocationINTENT TO USE SECTION 2021-08-31
Basis1(b)
Class StatusACTIVE
Primary US Classes
  • 021: Electrical Apparatus, Machines and Supplies
  • 023: Cutlery, Machinery, Tools and Parts Thereof
  • 026: Measuring and Scientific Appliances
  • 036: Musical Instruments and Supplies
  • 038: Prints and Publications
Primary International Class
  • 009 - Primary Class
  • (Electrical and scientific apparatus) Scientific, nautical, surveying, electric, photographic, cinematographic, optical, weighing, measuring, signaling, checking (supervision), lifesaving and teaching apparatus and instruments; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus.
Filed UseNo
Current UseNo
Intent To UseYes
Filed ITUYes
44D FiledNo
44E CurrentNo
66A CurrentNo
Current BasisNo
No BasisNo
Attorney NameKarl M. Zielaznicki, Esq.
Attorney Docket Number255546000014

Timeline

2020-07-01Application Filed
2020-07-04Location: NEW APPLICATION PROCESSING
2020-07-04Status: Live/Pending
2020-07-04Transaction Date
2021-07-06Published
2021-08-31Location: INTENT TO USE SECTION
2021-08-31Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six
2022-05-24Trademark Registered

Trademark Parties (Applicants & Owners)

Party: Takeda Pharmaceuticals U.S.A., Inc.
AddressOne Takeda Parkway Deerfield, ILLINOIS UNITED STATES 60015
Legal Entity TypeCorporation
Legal Entity StateDELAWARE

Attorney of Record

KARL M. ZIELAZNICKI, ESQ.
TROUTMAN PEPPER HAMILTON SANDERS LLP
875 THIRD AVENUE
C/O IP SERVICES NYC
NEW YORK, NY 10022

Good, Services, and Codes


IC 009. US 021 023 026 036 038. G & S: Downloadable predictive analytic software tools for use in patient healthcare
IC 042. US 100 101. G & S: Providing temporary use of online non-downloadable predictive analytical software tools for use in patient healthcare
IC 044. US 100 101. G & S: Pharmaceutical patient support programs providing inflammatory bowel patients, patient caregivers and healthcare professionals with healthcare information about treatments, disease management, support and counseling; health care and disease management services provided to patients in the nature of disease management programs, namely, monitoring, analyzing and management of patient's health data, treatments and prescriptions

International Codes:9
U.S. Codes:021,023,026,036,038
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0091Predictive analytic software tools for use in patient healthcare
GS0441Pharmaceutical patient support programs providing inflammatory bowel patients, patient caregivers and healthcare professionals with healthcare information about treatments, disease management, support and counseling; health care and disease management services provided to patients in the nature of disease management programs, namely, monitoring, analyzing and management of patient's health data, treatments and prescriptions

Trademark Filing History

DescriptionDateProceeding Number
NOA E-MAILED - SOU REQUIRED FROM APPLICANT2021-08-31
PUBLISHED FOR OPPOSITION2021-07-06
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED2021-07-06
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED2021-06-16
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED2021-05-286328
EXAMINERS AMENDMENT E-MAILED2021-05-286328
EXAMINERS AMENDMENT -WRITTEN2021-05-2887033
EXAMINER'S AMENDMENT ENTERED2021-05-2888888
APPROVED FOR PUB - PRINCIPAL REGISTER2021-05-28
ASSIGNED TO EXAMINER2021-05-2487033
TEAS/EMAIL CORRESPONDENCE ENTERED2021-04-2888889
TEAS RESPONSE TO OFFICE ACTION RECEIVED2021-04-27
CORRESPONDENCE RECEIVED IN LAW OFFICE2021-04-2788889
NOTIFICATION OF NON-FINAL ACTION E-MAILED2021-01-226325
NON-FINAL ACTION WRITTEN2021-01-2294643
NON-FINAL ACTION E-MAILED2021-01-226325
NOTIFICATION OF NON-FINAL ACTION E-MAILED2020-10-076325
NON-FINAL ACTION WRITTEN2020-10-0794643
NON-FINAL ACTION E-MAILED2020-10-076325
ASSIGNED TO EXAMINER2020-10-0694643
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM2020-07-30
NEW APPLICATION ENTERED IN TRAM2020-07-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed